Franklin Resources
CYCN icon

Franklin Resources’s Cyclerion Therapeutics CYCN Stock Holding History

Franklin Resources’s Portfolio CYCN Stock Details CYCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,946
Closed -$34.2K – 2732
2023
Q1 		$34.2K Hold
3,946
– – ﹤0.01% 2221
2022
Q4 		$51.8K Hold
3,946
– – ﹤0.01% 2214
2022
Q3 		$68K Buy
3,946
+46
+1% +$791 ﹤0.01% 2164
2022
Q2 		$43K Sell
3,900
-1,882
-33% -$27K ﹤0.01% 2256
2022
Q1 		$128K Hold
5,782
– – ﹤0.01% 2247
2021
Q4 		$199K Sell
5,782
-20
-0.3% -$945 ﹤0.01% 2242
2021
Q3 		$356K Buy
+5,802
New +$380K ﹤0.01% 2020

Other funds holding CYCN

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Franklin Resources's CYCN Position: Q2 2023 in Review

Franklin Resources sold out of Cyclerion Therapeutics (CYCN) in Q2 2023, closing a stake of 3,946 shares — an estimated $34.2K sold.

Franklin Resources first reported a position in CYCN in Q3 2021 and held it in 7 quarters. The position peaked at $356K in Q3 2021. 18 funds tracked by Wall St. Rank hold CYCN as of Q2 2023.

  • Franklin Resources reported no remaining Cyclerion Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Franklin Resources sold 3,946 Cyclerion Therapeutics shares in Q2 2023, an estimated $34.2K.
  • Franklin Resources first reported a position in Cyclerion Therapeutics in Q3 2021 and held it in 7 quarters.
  • Franklin Resources's Cyclerion Therapeutics position peaked at $356K in Q3 2021.
  • 18 funds tracked by Wall St. Rank held Cyclerion Therapeutics as of Q2 2023.

Based on Franklin Resources's 13F filing for Q2 2023, filed 11 Aug 2023.